Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Dyadic International (DYAI)

Dyadic International (DYAI)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 151,907
  • Shares Outstanding, K 28,079
  • Annual Sales, $ 1,600 K
  • Annual Income, $ -9,330 K
  • 60-Month Beta 0.06
  • Price/Sales 94.12
  • Price/Cash Flow N/A
  • Price/Book 7.14
Trade DYAI with:

Options Overview Details

View History
  • Implied Volatility 125.76%
  • Historical Volatility 80.45%
  • IV Percentile 69%
  • IV Rank 34.38%
  • IV High 263.93% on 10/09/20
  • IV Low 53.38% on 06/16/21
  • Put/Call Vol Ratio 0.11
  • Today's Volume 611
  • Volume Avg (30-Day) 646
  • Put/Call OI Ratio 0.24
  • Today's Open Interest 2,529
  • Open Int (30-Day) 4,191

Price Performance

See More
Period Period Low Period High Performance
1-Month
4.64 +24.06%
on 08/23/21
6.89 -16.55%
on 08/26/21
+1.03 (+21.82%)
since 08/20/21
3-Month
3.15 +82.54%
on 07/15/21
6.89 -16.55%
on 08/26/21
+1.99 (+52.93%)
since 06/21/21
52-Week
3.15 +82.54%
on 07/15/21
8.78 -34.51%
on 03/22/21
-1.86 (-24.44%)
since 09/21/20

Most Recent Stories

More News
Dyadic to Present at H.C. Wainwright 23rd Annual Global Investment Conference

Dyadic International, Inc. ("Dyadic", "we", "us", "our", or the "Company") (NASDAQ:DYAI), a global biotechnology company focused on further improving, applying, and deploying its proprietary C1-cell protein...

DYAI : 5.75 (+6.28%)
The Vaccine Revolution Portfolio (MRNA, PFE, JNJ, NVAX, BNTX, AZN, DYAI)

JNJ : 164.53 (+0.44%)
SRNE : 8.00 (+0.38%)
DYAI : 5.75 (+6.28%)
NVAX : 230.29 (+1.49%)
MRNA : 434.04 (+2.53%)
PFE : 43.92 (-0.63%)
BNTX : 341.35 (+0.69%)
AZN : 59.13 (+1.08%)
Desperation on Variants Paints Path for Long-Term Vaccine Thesis (DYAI, MRNA, PFE, JNJ, NVAX, BNTX, AZN, SRNE)

MRNA : 434.04 (+2.53%)
NVAX : 230.29 (+1.49%)
AZN : 59.13 (+1.08%)
BNTX : 341.35 (+0.69%)
PFE : 43.92 (-0.63%)
SRNE : 8.00 (+0.38%)
DYAI : 5.75 (+6.28%)
JNJ : 164.53 (+0.44%)
Dyadic Reports Second Quarter 2021 Financial Results and Highlights Recent Company Progress

Dyadic International, Inc. ("Dyadic", "we", "us", "our", or the "Company") (NASDAQ:DYAI), a global biotechnology company focused on further improving, applying, and deploying its proprietary C1-cell protein...

FSNN : 0.0580 (-19.44%)
SRNE : 8.00 (+0.38%)
DYAI : 5.75 (+6.28%)
Vaccine Plays in Focus as the World Searches for a Long-term Solution (MRNA, DYAI, NVAX, JNJ, AZN, BNTX, PFE)

JNJ : 164.53 (+0.44%)
AZN : 59.13 (+1.08%)
BNTX : 341.35 (+0.69%)
PFE : 43.92 (-0.63%)
MRNA : 434.04 (+2.53%)
SRNE : 8.00 (+0.38%)
DYAI : 5.75 (+6.28%)
NVAX : 230.29 (+1.49%)
Dyadic and Sorrento Announce Binding Term Sheet to License Dyadic's Lead COVID-19 Vaccine Candidate "DYAI-100" and C1 Technology for Protein-Based Coronavirus Vaccines and Therapeutics

Dyadic International, Inc. ("Dyadic", "we", "us", "our", or the "Company") (NASDAQ: DYAI), a global biotechnology company focused on further improving, applying and deploying its proprietary C1-cell protein...

DYAI : 5.75 (+6.28%)
SRNE : 8.00 (+0.38%)
The Covid Vaccine Market is a Long Game in the Early Innings (BNTX, AZN, DYAI, NVAX, MRNA, PFE, JNJ)

AZN : 59.13 (+1.08%)
NVAX : 230.29 (+1.49%)
PFE : 43.92 (-0.63%)
JNJ : 164.53 (+0.44%)
BNTX : 341.35 (+0.69%)
DYAI : 5.75 (+6.28%)
MRNA : 434.04 (+2.53%)
Dyadic Int'l (DYAI) Inks Deal Toward Potential Access to 40% of the World as Covid Vaccine Continues in Development

NVAX : 230.29 (+1.49%)
MRNA : 434.04 (+2.53%)
PFE : 43.92 (-0.63%)
JNJ : 164.53 (+0.44%)
BNTX : 341.35 (+0.69%)
AZN : 59.13 (+1.08%)
IBB : 171.56 (+0.97%)
DYAI : 5.75 (+6.28%)
Dyadic Announces Technology Transfer and Licensing Agreement With South Africa's Rubic Consortium Aiming to Develop and Commercialize Vaccines for Distribution Throughout the African Continent

-- Arrangement includes C1 COVID-19 vaccine technology transfer and licensing agreement

DYAI : 5.75 (+6.28%)
Delta Means Beta Testing Alpha Strategies in Biotech (NVAX, MRNA, DYAI, PFE, JNJ, BNTX, AZN, IBB)

PFE : 43.92 (-0.63%)
JNJ : 164.53 (+0.44%)
BNTX : 341.35 (+0.69%)
AZN : 59.13 (+1.08%)
IBB : 171.56 (+0.97%)
NVAX : 230.29 (+1.49%)
DYAI : 5.75 (+6.28%)
MRNA : 434.04 (+2.53%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 48% Buy with a Strengthening short term outlook on maintaining the current direction.

See More Share

Business Summary

Dyadic International, Inc. is a leading genomics company with the groundbreaking technology that brings nature to the marketplace. Dyadic is poised to become a global leader in proteomics through the discovery, development, and manufacturing of novel products derived from the DNA of complex living organisms...

See More

Key Turning Points

3rd Resistance Point 6.45
2nd Resistance Point 6.15
1st Resistance Point 5.95
Last Price 5.75
1st Support Level 5.45
2nd Support Level 5.15
3rd Support Level 4.94

See More

52-Week High 8.78
Fibonacci 61.8% 6.63
Fibonacci 50% 5.97
Last Price 5.75
Fibonacci 38.2% 5.30
52-Week Low 3.15

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar